Published September 25, 2013 | Version v1
Journal article

Tumor necrosis factor-α attenuates starvation-induced apoptosis through upregulation of ferritin heavy chain in hepatocellular carcinoma cells

  • 1. Tumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai Road, Shanghai 200438 (China)
  • 2. Medical Sciences Research Center, renji hospital, school of medicine, Shanghai jiaotong University, Shanghai (China)

Description

Tumor microenviroment is characteristic of inflammation, ischemia and starvation of nutrient. TNF-α, which is an extraordinarily pleiotropic cytokine, could be an endogenous tumor promoter in some tumor types. The basic objective of this study was to investigate the effects of TNF-α on the cell viability and apoptosis of hepatocellular carcinoma cells under serum starvation, and to identify the molecular mechanisms involved. For this purpose, five different concentrations of TNF-α and two different serum settings (serum-cultured and serum-deprived) were used to investigate the effects of TNF-α on the cell viability and apoptosis of Hep3B and SMMC-7721 cells. TNF-α (10 ng/ml) attenuated serum starvation-induced apoptosis of hepatocellular carcinoma cells, and autophagy conferred this process. BAY11-7082, a specific inhibitor of NF-κB, reversed the suppression of serum starvation-induced apoptosis by TNF-α. Moreover, TNF-α-induced NF-κB transactivation was suppressed by autophagy inhibitor 3-MA. In addition, TNF-α up-regulated Ferritin heavy chain (FHC) transiently by NF-κB activation and FHC levels were correlated with the TNF-α-induced protection against serum starvation-mediated apoptosis of hepatocellular carcinoma cells. Furthermore, FHC-mediated inhibition of apoptosis depended on suppressing ROS accumulation. Our findings suggested that autophagy conferred the TNF-α protection against serum starvation-mediated apoptosis of hepatocellular carcinoma cells, the mechanism involved with the activation of the TNF-α/ NF-κB /FHC signaling pathway

Availability note (English)

Available from http://dx.doi.org/10.1186/1471-2407-13-438; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849379

Additional details

Publishing Information

Journal Title
BMC cancer (Online)
Journal Volume
13
Journal Page Range
p. 438
ISSN
1471-2407

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46123823
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
APOPTOSIS; BUILDUP; FASTING; FERRITIN; HEPATOMAS; INHIBITION; SAFETY; VIABILITY
Descriptors DEC
CARCINOMAS; COMPLEXES; DISEASES; IRON COMPLEXES; METALLOPROTEINS; NEOPLASMS; ORGANIC COMPOUNDS; PROTEINS; TRANSITION ELEMENT COMPLEXES

Optional Information

Copyright
Copyright (c) 2013 Kou et al.
Notes
PMCID: PMC3849379; PUBLISHER-ID: 1471-2407-13-438; PMID: 24066693; OAI: oai:pubmedcentral.nih.gov:3849379; licensee BioMed Central Ltd.